Ratings by Brookline Capital Markets
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 8/19/2026 | Leah Rush Cann | Moderna | MRNA | Maintain | Buy (N/A) |
135.00 (N/A) |
|
Details | |
| 8/18/2026 | Kemp Dolliver | Outlook Therapeutics Inc. | OTLK | Maintain | Buy (N/A) |
4.00 (6.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 303 more... | |||||||||
